StockWatch
·
Pharmaceuticals
Quarterly Result12 Feb 2026, 01:32 pm

Star Source Multi Trade Ltd Reports Q3 and Nine Months Financial Results for 2025

AI Summary

Star Source Multi Trade Ltd. (Formerly known as Chemo Pharma Laboratories Limited) announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations for the nine-month period stood at ₹ 5,256.56 Thousand, with a net profit before exceptional items and tax of ₹ 6,818.00 Thousand. The board of directors approved the financial results, which were also reviewed by the audit committee.

Key Highlights

  • Revenue from operations for the nine months ended at ₹ 5,256.56 Thousand
  • Net profit before exceptional items and tax for the period was ₹ 6,818.00 Thousand
  • The financial results were reviewed by the audit committee and approved by the board of directors
  • Star Source Multi Trade Ltd. (Formerly known as Chemo Pharma Laboratories Limited)